JPMorgan Chase & Co’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $44.1M | Buy |
764,997
+48,664
| +7% | +$2.8M | ﹤0.01% | 1273 |
|
2025
Q1 | $41.7M | Buy |
716,333
+101,167
| +16% | +$5.89M | ﹤0.01% | 1268 |
|
2024
Q4 | $49.5M | Sell |
615,166
-197,200
| -24% | -$15.9M | ﹤0.01% | 1185 |
|
2024
Q3 | $65.1M | Sell |
812,366
-84,381
| -9% | -$6.76M | ﹤0.01% | 1062 |
|
2024
Q2 | $54.8M | Buy |
896,747
+823,558
| +1,125% | +$50.3M | ﹤0.01% | 1096 |
|
2024
Q1 | $3.62M | Sell |
73,189
-47,058
| -39% | -$2.33M | ﹤0.01% | 2769 |
|
2023
Q4 | $5.04M | Sell |
120,247
-2,608
| -2% | -$109K | ﹤0.01% | 2556 |
|
2023
Q3 | $4.03M | Buy |
122,855
+896
| +0.7% | +$29.4K | ﹤0.01% | 2556 |
|
2023
Q2 | $4.31M | Buy |
121,959
+40,843
| +50% | +$1.44M | ﹤0.01% | 2591 |
|
2023
Q1 | $2.3M | Buy |
81,116
+51,679
| +176% | +$1.47M | ﹤0.01% | 2963 |
|
2022
Q4 | $1.22M | Buy |
29,437
+3,212
| +12% | +$133K | ﹤0.01% | 3251 |
|
2022
Q3 | $1.09M | Sell |
26,225
-39,189
| -60% | -$1.62M | ﹤0.01% | 3291 |
|
2022
Q2 | $2.14M | Buy |
65,414
+60,061
| +1,122% | +$1.96M | ﹤0.01% | 2961 |
|
2022
Q1 | $188K | Buy |
5,353
+825
| +18% | +$29K | ﹤0.01% | 4481 |
|
2021
Q4 | $113K | Buy |
+4,528
| New | +$113K | ﹤0.01% | 4769 |
|